Thoracic Surgeon-Scientist; Chief, Thoracic Surgery MSKCC; Oenophile.

New York, NY
Joined May 2023
Jones David R. retweeted
Thanks to everyone who stopped by and visited with us at #ESTS2026! If you didn’t get to meet with AATS 105th President @JonesDavid2013 in Athens, join us in September in NYC for #ITSOS2026: events.aats.org/internationa…
5
17
1,134
Jones David R. retweeted
Great to see Dr @JonesDavid2013 at ESTS @thoracic Annual Meeting in Athens. Always dapper! He inspires me, including to dress like him.
1
3
16
1,152
Jones David R. retweeted
Very proud of @JayBader_MD for his excellent job presenting radiographic predictors of neoadjuvant therapy response in NSCLC. #AATS2026 🩻PET better than CT 🎯Correlation between ⬇️ in size or SUVmax but plenty of exceptions limit accuracy 🧪Models need additional biomarkers
3
22
1,240
Congratulations to Dr. Linda Martin, our newly elected GTSC Chair and the first woman to lead the Club! We look forward to her leadership in this role over the next two years. @LindaMThoracic
2
10
3
50
5,839
So incredibly proud of @MHShahzad5 @ronirayes and @JonathanCools for getting this awesome review. The sum of so much work on Neutrophil Extracellular Trap biology in cancer and some insights on how we may transition to the therapeutic space, now 15 years since we first conceived that NETs might play a role in cancer progression! nature.com/articles/s41568-0…
2
11
1
41
4,004
Very excited to present on “The Tumor Microenvironment for Surgeons” @AATSHQ #itsos2025 🔬🦠🧫🧬👩‍🔬 I promise to make this topic applicable and interesting to all surgeons from the highly clinical to the surgeon-scientists Check it out Sat September 27 10:10am
1
7
39
3,108
While our judges deliberate the top 3 winners of MSK Postdoc Slam, let’s celebrate our #NPAW2025 📸 contest champs! 🎉 🥇 @MeganEKelley – Sfeir lab 🥈 @TomZhendong – @SawyersLabMSKCC 🥉 Manendra Lankadasari – @JonesDavid2013 lab Congrats to our amazing #MSKPostdocs @MSKPDA! 👏📷
5
1
19
2,622
Jones David R. retweeted
Today’s @IASLC #WCLC25 panel on resectable early-stage #lungcancer shows why patients & clinicians must work together across the whole perioperative pathway. Shared decision-making is essential to define real treatment benefit. Patient orgs can play big roles. @kamarroneMD Dr Oka
4
12
1
48
3,047
Jones David R. retweeted
The #ITSOS2025 G. Alexander Patterson Giants Lecture will be given by @DouglasEWood1 @uwsomwwami. See his talk on the science & policy behind lung cancer screenings & how improvements will save lives. Rates increase in one week, so secure your spot today: events.aats.org/internationa…
1
1
12
871
Registration is open for @AATSHQ #ITSOS2025 in Boston! Excellent program highlighting latest data & innovations focused on multi-disciplinary thoracic surgical oncology! Register by the early rate deadline on 8/26: events.aats.org/internationa…
1
6
24
1,854
Jones David R. retweeted
The AATS is proud to announce the #ITSOS2025 Giants and Master Surgeon Lectures. Don't miss @DouglasEWood1, Malcolm M. DeCamp Jr., and Cameron D. Wright give talks dedicated to treating surgical thoracic oncology. Register today: events.aats.org/internationa…
1
4
1
23
2,443
Jones David R. retweeted
I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13) nature.com/articles/s41586-0…
14
69
1
249
18,740
Deadline for @AATSHQ #ITSOS2025 abstracts tomorrow This is one of the best thoracic surgical oncology meetings of the year. Get your abstracts in! See you in Boston this September
6
37
2,254
Jones David R. retweeted
New lung cancer research: Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) #NSCLC—how beneficial is it? Find out from surgeons in Tokyo by reading the study in #JTCVS: doi.org/10.1016/j.jtcvs.2024…
1
6
30
2,987
Jones David R. retweeted
I just heard huge news that needs to be celebrated! Today marks 40 years of research and care for Dr Mark Kris @MSKCancerCenter Dr Kris has been a champion for innovative research, playing a pivotal role in many advancements over the past 4 decades. His contributions to science have transformed lung cancer care nationally and internationally. Dr Kris has consistently pushed boundaries as a founder of the Lung Cancer Mutation Consortium and a pioneer in advocating for dose optimization, anti-nausea protocols before chemotherapy, and supportive care (when many considered side effects a trade-off for longer life). He mentored generations of oncologists who now lead departments and run major trials. Most importantly, he gave hope to patients and families when there wasn't much if any (many years). Thank you, Dr. Kris, for your tireless efforts and dedication to improving survival and quality of life for people diagnosed with lung cancer and our families! #LCSM
2
11
3
97
3,901
Reminder: A new TSOG-supported trial, TROPION-Lung12, is now available to be opened for accrual. If your site is interested in participating in the protocol, please email Kelly Travis at [email protected] or Maria Singh at [email protected].
2
8
364